AGP Executive Report
Last update: 9 hours agoTaiwan Health & Pharma: A Taiwanese CDMO, Mycenax Biotech, says it has achieved what appears to be the first publicly documented case of an AI-driven, physics-based digital twin clearing full GMP validation in a commercial biologic purification run, boosting recovery by 11%—a potential win for Taiwan’s drug manufacturing competitiveness as global compliance pressure rises. Clinical Safety: New research warns that long-term use of the erectile dysfunction drug tadalafil (Cialis) is linked to a higher risk of glaucoma, urging people on long-term therapy to get eye checks, especially if they have risk factors. Healthy Aging & Memory: A Singapore-led reminiscence card program is rolling out across Taiwan and other Asian markets, using guided life-story prompts to support cognitive health and ease depression symptoms in older adults. Coral & Wellness Science: Academia Sinica researchers report early-trial results suggesting probiotics may help coral cells adapt to heat stress and reduce bleaching risk, with Taiwan’s conservation agency planning monitoring and early-warning assessments. Diplomacy with Health in the Mix: Taiwan and Eswatini leaders reaffirm ties, highlighting cooperation areas that include healthcare, education, and digital transformation. Health Tech Market Watch: New reports track fast-growing demand for eClinical solutions and AI in medical imaging, reflecting continued investment in clinical trials and diagnostics tooling.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.